Brind.

Aethlon Medical received two Breakthrough Device Designations from the FDA and is moving forward with clinical trials.

1 report, 1 independent Updated Jun 17

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Aethlon Medical FDA

Keep exploring

The entities involved

Aethlon Medical
Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

Avexitide received FDA Breakthrough Therapy designation.Jun 8
The FDA recommended advancement for a new drug application submitted by a company.Jun 8

Coverage

Newest first; wire copies grouped

Jun 17proactiveinvestors.com.au